ShareValue scores for 603222.SHG: Valuation 43, Quality 20, Growth 45, Health 38.

603222.SHG
SSE

Zhejiang Chimin Pharm Co Ltd

CN¥8.77(+2.10%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

1% to 17%
Valuation
43
Fair Value
Price vs Value
Quality
20
Weak
Business Strength
Growth
45
Moderate
Revenue & Earnings
Health
38
Stressed
Financial Stability
Momentum
48
Neutral
Price Trend

Company Details

About

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture medical devices, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automated immunoassay monitoring and pylori Helicobacter detection kits. Further, it offers hemodialysis series products, including hemodialysis concentrate, and other products; and medical and health services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. and changed its name to Chimin Health Management Co., Ltd. in August 2018. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Taizhou, China. Address: No. 888, Beiyuan Road, Taizhou, China, 318020

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026